Lee Hambright
Stock Analyst at Bernstein
(3.59)
# 818
Out of 5,147 analysts
40
Total ratings
60%
Success rate
5.43%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $380 → $330 | $246.61 | +33.81% | 3 | Feb 19, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $154 → $125 | $116.35 | +7.43% | 7 | Jan 23, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $740 → $750 | $503.51 | +48.95% | 4 | Jan 23, 2026 | |
| MDLN Medline | Initiates: Outperform | $49 | $47.51 | +3.14% | 1 | Jan 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $97 → $99 | $98.44 | +0.57% | 2 | Jan 9, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Market Perform | $18 → $25 | $25.30 | -1.19% | 2 | Jan 9, 2026 | |
| SYK Stryker | Maintains: Outperform | $450 → $465 | $387.46 | +20.01% | 4 | Jan 9, 2026 | |
| MDT Medtronic | Maintains: Outperform | $111 → $112 | $97.66 | +14.68% | 4 | Jan 9, 2026 | |
| JNJ Johnson & Johnson | Maintains: Market Perform | $193 → $208 | $248.43 | -16.27% | 6 | Jan 9, 2026 | |
| DXCM DexCom | Maintains: Outperform | $84 → $86 | $73.43 | +17.12% | 3 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $92 → $100 | $76.85 | +30.12% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $86.47 | +56.12% | 3 | Mar 16, 2022 |
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $380 → $330
Current: $246.61
Upside: +33.81%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $154 → $125
Current: $116.35
Upside: +7.43%
Intuitive Surgical
Jan 23, 2026
Maintains: Outperform
Price Target: $740 → $750
Current: $503.51
Upside: +48.95%
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $49
Current: $47.51
Upside: +3.14%
Zimmer Biomet Holdings
Jan 9, 2026
Maintains: Market Perform
Price Target: $97 → $99
Current: $98.44
Upside: +0.57%
Tandem Diabetes Care
Jan 9, 2026
Maintains: Market Perform
Price Target: $18 → $25
Current: $25.30
Upside: -1.19%
Stryker
Jan 9, 2026
Maintains: Outperform
Price Target: $450 → $465
Current: $387.46
Upside: +20.01%
Medtronic
Jan 9, 2026
Maintains: Outperform
Price Target: $111 → $112
Current: $97.66
Upside: +14.68%
Johnson & Johnson
Jan 9, 2026
Maintains: Market Perform
Price Target: $193 → $208
Current: $248.43
Upside: -16.27%
DexCom
Jan 9, 2026
Maintains: Outperform
Price Target: $84 → $86
Current: $73.43
Upside: +17.12%
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $76.85
Upside: +30.12%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $86.47
Upside: +56.12%